Stocks and Investing Stocks and Investing
Tue, August 2, 2022

Matthew O"Brien Maintained (ZBH) at Hold with Decreased Target to $120 on, Aug 2nd, 2022


Published on 2024-10-27 22:22:36 - WOPRAI, Matthew O'Brien
  Print publication without navigation


Matthew O"Brien of Piper Sandler, Maintained "Zimmer Biomet Holdings, Inc." (ZBH) at Hold with Decreased Target from $130 to $120 on, Aug 2nd, 2022.

Matthew has made no other calls on ZBH in the last 4 months.

There are 7 other peers that have a rating on ZBH. Out of the 7 peers that are also analyzing ZBH, 5 agree with Matthew"s Rating of Hold. Following are those relevant analyst calls for the last 4 months;

Cecilia Furlong of "Morgan Stanley" Maintained at Hold with Decreased Target to $115 on, Friday, July 15th, 2022
Mike Matson of "Needham" Downgraded from Strong Buy to Hold on, Friday, May 27th, 2022
Joanne Wuensch of "Citigroup" Maintained at Hold with Decreased Target to $125 on, Tuesday, May 17th, 2022
Shagun Singh of "RBC Capital" Maintained at Hold with Increased Target to $128 on, Wednesday, May 4th, 2022
Richard Newitter of "Truist Securities" Maintained at Hold with Decreased Target to $131 on, Wednesday, May 4th, 2022

These are the ratings of the 2 analyists that currently disagree with Matthew;

Rick Wise of "Stifel" Maintained at Strong Buy with Decreased Target to $120 on, Monday, July 18th, 2022
Danielle Antalffy of "SVB Leerink" Maintained at Buy with Increased Target to $140 on, Wednesday, May 4th, 2022

Contributing Sources